1. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424-47.

https://doi.org/10.1182/blood-2016-08-733196

PMid:27895058 PMCid:PMC5291965

2. Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136-52.

https://doi.org/10.1056/NEJMra1406184

PMid:26376137 

3. De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6:e441.

https://doi.org/10.1038/bcj.2016.50

PMid:27367478 PMCid:PMC5030376

4. Gil L, Styczynski J, Dytfeld D, Debski R, Kazmierczak M, Kolodziej B, et al. Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia. Anticancer Res. 2007;27:4021-5.

PMid:18225565

5. Styczynski J, Toporski J, Wysocki M, Debski R, Chybicka A, Boruczkowski D, et al. Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia. Anticancer Res. 2007;27:1547-51.

PMid:17595774

6. Çiftçiler R, Göker H, Demiroğlu H, Aldağ E, Aksu S, Haznedaroğlu IC, et al. Comparison of myeloablative versus reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: a cohort study. Turk J Haematol. 2019;36:88-96.

https://doi.org/10.4274/tjh.galenos.2019.2018.0220

PMid:30717586 PMCid:PMC6516104

7. Dorocka-Bobkowska B, Düzgüneş N, Konopka K. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines but do not cause yeast detachment. Med Sci Monit. 2009;15:262-9.

PMid:19721394

8. Basile D, Di Nardo P, Corvaja C, Garattini SK, Pelizzari G, Lisanti C, et al. Mucosal injury during anti-cancer treatment: from pathobiology to bedside. Cancers (Basel). 2019;11:pii:E857.

https://doi.org/10.3390/cancers11060857

PMid:31226812 PMCid:PMC6627284

9. Hassona Y, Scully C. Salivary changes in oral mucosal diseases. Periodontology 2000. 2016;70:111-27.

https://doi.org/10.1111/prd.12102

PMid:26662486 

10. Peeters FP, deVries MW, Vissink A. Risks for oral health with the use of antidepressants. Gen Hosp Psychiatr. 1998;20:150-4.

https://doi.org/10.1016/S0163-8343(98)00017-6

PMid:9650032

11. Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P, et al. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;38:101-9.

https://doi.org/10.1038/sj.bmt.1705406

PMid:16751786 

12. Schubert MM, Sullivan KM, Morton TH, Izutsu KT, Peterson DE, Flournoy N, et al. Oral manifestations of chronic graft-v-host disease. Arch Intern Med. 1984;144:1591-5.

https://doi.org/10.1001/archinte.1984.00350200087014

PMid:6380439 

13. Hou GL, Huang JS, Tsai CC. Analysis of oral manifestations of leukemia: a retrospective study. Oral Dis. 1997;3:31-8.

https://doi.org/10.1111/j.1601-0825.1997.tb00006.x

PMid:9456644 

14. Guan G, Firth N. Oral manifestations as an early clinical sign of acute myeloid leukaemia: a case report. Aust Dent J. 2015;60:123-7.

https://doi.org/10.1111/adj.12272

PMid:25721286 

15. Laaksonen MJ. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation. Dent Res. 2011;90:1177-82.

https://doi.org/10.1177/0022034511414156

PMid:21734227 

16. van Leeuwen SJM. Salivary changes before and after hematopoietic stem cell transplantation: A systematic review. Biol Blood Marrow Transplant. 2019;25:1055-61.

https://doi.org/10.1016/j.bbmt.2019.01.026

PMid:30710684 

17. Ślebioda Z, Łukaszewska-Kuska M, Dorocka-Bobkowska B. Evaluation of the efficacy of treatment modalities in burning mouth syndrome- a systematic review. J Oral Rehabil. 2020;47:1435-47.

https://doi.org/10.1111/joor.13102

PMid:32979878 

18. Brand HS, Bots CP, Raber-Durlacher JE. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Br Dent J. 2009;14:207-9.

https://doi.org/10.1038/sj.bdj.2009.977

PMid:19893563 

19. Epstein JB, Villines D, Epstein GL, Smutzer G. Oral examination findings, taste and smell testing during and following head and neck cancer therapy. Support Care Cancer. 2020;28:4305-11.

https://doi.org/10.1007/s00520-019-05232-y

PMid:31912362 

20. Wolff A, Joshi RK, Ekström J, Aframian D, Pedersen AM, Proctor G, et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D. 2017;17:1-28.

https://doi.org/10.1007/s40268-016-0153-9

PMid:27853957 PMCid:PMC5318321

21. Piatkowska-Jakubas B, Darczuk D, Chomyszyn-Gajewska M, Skotnicki AB. Mucositis- a major non-hematologic complication of high-dose chemotherapy and radiotherapy--pathogenesis, prevention and treatment. Przegl Lek. 2003;60:815-20.

PMid:15058023

22. Gomes AO, Torres SR, Maiolino A, Dos Santos CW, Silva Junior A, Correa ME, et al. Early and late oral features of chronic graft-versus-host disease. Rev Bras Hematol Hemoter. 2014;36:43-9.

https://doi.org/10.5581/1516-8484.20140012

PMid:24624035

23. Bogusławska-Kapała A, Cackowska-Lass A, Balon J, Hellmann A, Kochańska B. Saliva secretion and abnormal moistening of oral mucosa after bone marrow transplantation. Bull Group Int Rech Sci Stomatol Odontol. 2006;47:1-5.

PMid:17672198

24. Nakamura S, Hiroki A, Shinohara M, Gondo H, Ohyama Y, Mouri T, et al. Oral involvement in chronic graft-versus-host disease after allogenic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:556-63.

https://doi.org/10.1016/S1079-2104(96)80203-4

PMid:8936521

25. Andersson I, Ahlberg K, Stockelberg D, Persson LO. Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation. Eur J Cancer Care. 2011;20:368-79.

https://doi.org/10.1111/j.1365-2354.2009.01174.x

PMid:20345452 

26. Andersson I. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning. Cancer Nurs. 2009;3:325-34.

https://doi.org/10.1097/NCC.0b013e31819b5c81

PMid:19444087 

27. Cammarata-Scalisi F, Girardi K, Strocchio L, Merli P, Garret-Bernardin A, Galeotti A, et al. Oral manifestations and complications in childhood acute myeloid leukemia. Cancers (Basel). 2020;12:1634.

https://doi.org/10.3390/cancers12061634

PMid:32575613 PMCid:PMC7352340

28. Valéra MC, Noirrit-Esclassan E, Pasquet M, Vaysse F. Oral complications and dental care in children with acute lymphoblastic leukaemia. J Oral Pathol Med. 2015;44:483-9.

https://doi.org/10.1111/jop.12266

PMid:25243950 

29. Sonis ST. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007;5:3-11.

PMid:18046993

30. Epstein JB, de Andrade E Silva SM, Epstein GL, Leal JHS, Barasch A, Smutzer G. Taste disorders following cancer treatment: report of a case series. Support Care Cancer. 2019;27:4587-95.

https://doi.org/10.1007/s00520-019-04758-5

PMid:30927113